Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
7d agoen
From the article
Conditions : Diffuse Intrinsic Pontine Glioma; DIPG; Brain Tumor; CNS Tumor; Central Nervous System Tumor; Pediatric Cancer; Adult Cancer Patients; CNS Tumor, Childhood; CNS Tumor, Adult; Brainstem Glioma; Diffuse Midline Glioma; DMG Interventions : Biological: BCB-276 Sponsors : BrainChild Bio, Inc Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature Communications·8d ago

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·13d ago
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial
doi.org·6d ago
Clinical trial explores high-dose vitamin B3 as potential treatment for glioblastoma brain cancer
A clinical trial is exploring whether high doses of vitamin B3 (niacin) could help patients with glioblastoma, an aggressive and deadly brai
sciencedaily.com·15d ago

OHSU logra un gran avance en la ciencia médica con las terapias celulares
Oregon Health & Sciences University·12d ago
China approves world's first CAR-T cell therapy for solid tumors: CARsgen's satri-cel for advanced gastric cancer
CARsgen Therapeutics has received approval from China's NMPA for satricabtagene autoleucel (satri-cel; CT041), the world's first CAR-T cell
insideprecisionmedicine.com·13d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.